Could a common allergy drug soothe Kids' chronic stomach pain?
NCT ID NCT02484248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether ketotifen, a drug that stabilizes certain immune cells, can reduce stomach pain in children aged 8-17 with functional dyspepsia and high levels of eosinophils in the gut. Participants will receive both ketotifen and a placebo at different times to compare effects. The goal is to see if ketotifen can be a simpler, cheaper treatment option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Children's Mercy Hospital
RECRUITINGKansas City, Missouri, 64108, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wheat sensitivity linked to fatty liver? a new study investigates
- Ancient herbal mix targets dual gut disorders in one shot
- Digestive health mystery: study seeks to uncover hidden burden of stomach pain in rural bangladesh
- New hope for chronic stomach pain: DA-9701 put to the test
- Could ginger and perilla replace acid pills for stomach trouble?
- Gut bacteria mystery: 200 patients to help uncover hidden cause of stomach pain